Pierre Fabre Laboratories and Vernalis announce a drug discovery collaboration in oncology

Pierre Fabre Laboratories and Vernalis Ltd, a fully owned subsidiary of HitGen Inc., are pleased to announce a long-term partnership to identify pre-clinical candidates against multiple oncology targets.